Mucoadhesive chitosan-modified PLGA nanoparticles loaded with green tea extract inhibit amyloid β peptide aggregation and oxidative stress

Alzheimer's disease (AD) is associated with amyloid β (Aβ) plaque deposition in the brain, which leads to neurotoxicity through inflammation and oxidative stress. Green tea has shown promise in treating AD due to its anti-amyloidogenic, anti-inflammatory, and antioxidant properties. However, the therapeutic efficacy of green tea extract (GTE) is limited by the low bioavailability of its main constituents and their poor ability to cross the blood-brain barrier. Nanoparticles (NPs) designed for nose-to-brain delivery offer a solution by enhancing the targeted delivery of GTE to the brain. In this study, poly(lactic- co -glycolic) acid (PLGA) NPs modified with chitosan (Ch) were developed for brain delivery of GTE. GTE-loaded Ch-modified PLGA NPs exhibited suitable physicochemical characteristics for brain delivery, including a spherical morphology with an average diameter of 274 ± 15 nm and a uniform size distribution. The NPs showed an encapsulation efficiency of 41 ± 8 % and a positive zeta potential of 9 ± 4 mV. They retained their colloidal stability in storage conditions for up to 3 months, and the release kinetics demonstrated a controlled and sustained release profile, with 32 ± 10 % of GTE released over 6 days. Additionally, the NPs' mucoadhesive properties were confirmed through their interactions with mucin. Importantly, the NPs exhibited strong anti-amyloidogenic activity by effectively preventing Aβ aggregation, along with an antioxidant activity of 88 ± 4 %. This study provides valuable insights into the potential of mucoadhesive PLGA NPs for GTE delivery, representing a significant advancement in therapeutic strategies for managing AD by targeting critical disease mechanisms. • NPs exhibited suitable size, stability, and positive zeta potential. • GTE was released from NPs in a sustained manner for up to 6 days. • Chitosan-modified NPs showed strong mucoadhesive properties. • GTE-loaded NPs prevented Aβ aggregation and showed 88 % antioxidant activity.

Authors

Institutions

Publication Details

Journal
Journal of Molecular Liquids
Published
2025-10-03
DOI
https://doi.org/10.1016/j.molliq.2025.128650
Citations
2
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
2.33
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mucoadhesive chitosan-modified PLGA nanoparticles loaded with green tea extract inhibit amyloid β peptide aggregation and oxidative stress

Maria João Ramalho, Joana A. Loureiro, Maria do Carmo Pereira, Stéphanie Andrade
2 citations
Journal of Molecular Liquids
Alzheimer's disease research and treatments
2.33
article

Mucoadhesive chitosan-modified PLGA nanoparticles loaded with green tea extract inhibit amyloid β peptide aggregation and oxidative stress

Maria João Ramalho, Joana A. Loureiro, Maria do Carmo Pereira, Stéphanie Andrade
article en
2 citations

Abstract

Alzheimer's disease (AD) is associated with amyloid β (Aβ) plaque deposition in the brain, which leads to neurotoxicity through inflammation and oxidative stress. Green tea has shown promise in treating AD due to its anti-amyloidogenic, anti-inflammatory, and antioxidant properties. However, the therapeutic efficacy of green tea extract (GTE) is limited by the low bioavailability of its main constituents and their poor ability to cross the blood-brain barrier. Nanoparticles (NPs) designed for nose-to-brain delivery offer a solution by enhancing the targeted delivery of GTE to the brain. In this study, poly(lactic- co -glycolic) acid (PLGA) NPs modified with chitosan (Ch) were developed for brain delivery of GTE. GTE-loaded Ch-modified PLGA NPs exhibited suitable physicochemical characteristics for brain delivery, including a spherical morphology with an average diameter of 274 ± 15 nm and a uniform size distribution. The NPs showed an encapsulation efficiency of 41 ± 8 % and a positive zeta potential of 9 ± 4 mV. They retained their colloidal stability in storage conditions for up to 3 months, and the release kinetics demonstrated a controlled and sustained release profile, with 32 ± 10 % of GTE released over 6 days. Additionally, the NPs' mucoadhesive properties were confirmed through their interactions with mucin. Importantly, the NPs exhibited strong anti-amyloidogenic activity by effectively preventing Aβ aggregation, along with an antioxidant activity of 88 ± 4 %. This study provides valuable insights into the potential of mucoadhesive PLGA NPs for GTE delivery, representing a significant advancement in therapeutic strategies for managing AD by targeting critical disease mechanisms. • NPs exhibited suitable size, stability, and positive zeta potential. • GTE was released from NPs in a sustained manner for up to 6 days. • Chitosan-modified NPs showed strong mucoadhesive properties. • GTE-loaded NPs prevented Aβ aggregation and showed 88 % antioxidant activity.

Journal of Molecular LiquidsVol. 437
Universidade do Porto (PT)
Openalex Percentile: Top 10%
Alzheimer's disease research and treatments
2.33
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.